Now live: Pro — the full 13F research suite for serious investorsSee pricing →
22NW, LP

Q4 2023 · 13F-HR

22NW, LPholdings as filed

Filed 2024-02-14 · accession 0001214659-24-002898

$153.5M
Reported value
14
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
859241101STRLSTERLING INFRASTRUCTURE INC$32.5M21.1%369,222CommonSOLE
350060109FSTRFOSTER L B CO$28.9M18.8%1,313,121CommonSOLE
L72967109OECORION S.A.$20.4M13.3%736,472CommonSOLE
034569103ANEBANEBULO PHARMACEUTICALS INC$13.0M8.46%5,366,290CommonSOLE
514766104LFCRLIFECORE BIOMEDICAL INC$10.9M7.08%1,755,161CommonSOLE
53000N108LIANYLIANBIO$9.9M6.44%2,211,678CommonSOLE
068463108BBSIBARRETT BUSINESS SVCS INC$7.7M5.00%66,226CommonSOLE
230215105CULPCULP INC$7.0M4.57%1,212,380CommonSOLE
307675108FB1FARMER BROS CO$6.0M3.90%1,955,526CommonSOLE
563571405MTWMANITOWOC CO INC$5.9M3.87%356,115CommonSOLE
71742W103PFXPHENIXFIN CORP$5.0M3.24%117,885CommonSOLE
86272A206SSKNEURSTRATA SKIN SCIENCES INC$3.0M1.92%5,369,954CommonSOLE
516544103LNTHLANTHEUS HLDGS INC$2.7M1.74%43,000CommonSOLE
744375205PMDUSDPSYCHEMEDICS CORP$812,2770.53%274,418CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.